RARA CRAFT DATABASE for FDA Medical Devices
510(k)K151256

FDA DEVICE FACTS

Arthrex BioSync® Bone Wedge

Arthex, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 12, 2015PRODUCT CODEPLF

Indications for use

The Arthrex BioSync Bone Wedge is intended to be used for internal bone fixation for bone fractures, fusions, or osteotomies in the ankle and foot, such as: Cotton and Evans Wedges:

• Opening wedge osteotomies of the bones of the foot including osteotomies for Hallux Valgus

• Opening wedge of Medial Cuneiform or Cotton osteotomies

• Lateral Column Lengthening (Evans Lengthening Osteotomy of Calcaneal Z Osteotomy)

• Metatarsal/Cuneiform arthrodesis Midfoot Wedges:

• Opening wedge osteotomies of the bones of the foot including osteotomies for Hallux Valgus

• Nonunion of arthrodesis of the Midfoot including Metatarsal/Cuneiform arthrodesis (TMT or Lapidus) This device is intended for use with ancillary fixation. The Arthrex BioSync Bone Wedge is not intended for use in the spine.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 5, 2026